Product Theaters & Non CME Sessions

PDA is happy to announce three Product Theaters/Non CME Educational sessions that will take place at The Palace Hotel during our 69th Annual Meeting.   Lunch will be provided for attendees at all Product Theaters/Non CME Educational sessions.

THURSDAY | August 17, 2017

12:15 pm - 1:45 pm
Lunch & Product Theater*
A Treatment Option for Moderate to Severe Pediatric Plaque Psoriasis
Jennifer Soung, MD, Southern California Dermatology
Presented by Amgen

FRIDAY | August 18, 2017

12:15 pm - 1:45 pm
Lunch & Product Theater*
Clinical Insights on Taltz
Jeffrey Crowley, MD, Bakersfield Dermatology & Skin Cancer Medical Group
Presented by Lilly

  • Review plaque psoriasis measurement and treatment options
  • Discuss Taltz efficacy and safety results in UNCOVER trial program
  • Present head-to-head Taltz vs ustekinumab clinical trial data
  • Review Important Safety Information for Taltz
  • Examine Dosing and Administration for Taltz


SATURDAY | August 19, 2017

12:15 pm - 1:45 pm
Lunch & Non-CME Educational Session*
New Horizons: Finally, Approaches to Treating Moderate-to-Severe Atopic Dermatitis

Mark Lebwohl, MD, Icahn School of Medicine at Mount Sinai

During this symposium, Dr Lebwohl will discuss a precision medicine approach to managing moderate to severe atopic dermatitis (AD). He will highlight management approaches to AD based on individual patient characteristics, pathogenesis of AD, guidelines, and efficacy and safety data for new and emerging treatments. In addition, Dr Lebwohl will share insights into working collaboratively with the patient and caregiver in AD. Finally, Dr Lebwohl will address education and engagement of the patient and caregiver in managing quality-of-life and adherence issues as well as describe approaches to shared decision-making.

This activity is supported by an independent medical educational grant from Genzyme, a Sanofi Company and Regeneron Pharmaceuticals.

*Please note that these are non-CME accredited sessions.